However, in a specific situation, cancer cells need not produce their own NE/EPI or release it in an autocrine manner in order to be responsive to propranolol treatment, as this medication or those in its family (carvedilol, nebivolol) may lower blood sugar by altering pancreatic insulin release or improving insulin sensitivity (151). The gene discussed is INS; the disease is cancer.